Friday 9 January 2015

U.S. FDA approves Daiichi anti-clotting drug

(Reuters) - U.S. regulators on Thursday approved the use of a drug made by Daiichi Sankyo Co Ltd to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem. The new drug, Savaysa, will compete with older blood thinners, including Xarelto, sold by Bayer AG and Johnson & Johnson, Boehringer Ingelheim's Pradaxa, and Bristol-Myers Squibb Co's Eliquis. ... via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment